Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinomaDevalingam Mahalingam, Steffan T. Nawrocki, Jennifer S. Carew et al.|British Journal of Cancer|2011Cited by 28
Targeting PIM kinase activity significantly augments the efficacy of cytarabineKevin R. Kelly, Jennifer S. Carew, Claudia M. Espitia et al.|British Journal of Haematology|2011Cited by 22
Abstract B272: The novel PIM kinase inhibitor SGI-1776 significantly enhances the preclinical activity of sunitinib in renal cell carcinomaDevalingam Mahalingam, Steffan T. Nawrocki, Ernest Medina et al.|Molecular Cancer Therapeutics|2009Cited by 0
Targeting Pim Kinase Activity with the Novel Small Molecule Inhibitor SGI-1776 Significantly Augments the Efficacy of Cytarabine In Models of Acute Myeloid LeukemiaKevin R. Kelly, Jennifer S. Carew, Steffan T. Nawrocki et al.|Blood|2010Cited by 0